期刊文献+

血清PSA与前列腺癌病理分级临床分期相关性研究 被引量:3

The relationships among clinical stage, pathological grade, PSA level in patients with prostate cancer
下载PDF
导出
摘要 目的 :探讨前列腺癌患者血清PSA与前列腺癌病理分级和临床分期的相关性。方法 :前列腺手术前检测PSA ,术后经病理检查确诊为前列腺癌患者 42例。根据苏木素 伊红染色切片中肿瘤的组织学形态 ,结合临床资料分别进行病理分级、临床分期。采用Spearman等级相关分析分析PSA与前列腺癌病理分级和临床分期的关系。结果 :PSA值与前列腺癌的病理分级有关 ,与前列腺癌临床分期间的关系目前尚无肯定的结论。结论 :PSA值不仅是前列腺癌的一个筛选指标 。 Purpose:To assess the relationships among clinical stage and pathological grade, serum PSA concentration in patients with prostate cancer. Methods:Clinical staging and pathological grading were carried out on the basis of pathological examination and clinic material in 42 prostate cancer patients treated by prostatectomy. PSA levels of patients were measured before the operation. By using Spearman rank correlation, the relationship between clinical stage and pathological stage, serum PSA concentration were evaluated. Results:Serum PSA concentration related well to pathological grade, but the relationship between PSA with clinical stage couldn't be confirmed. Conclusions:PSA is not only a powerful predictor of clinical diagnosis, but also a predictor of prognoses .
出处 《临床泌尿外科杂志》 2002年第12期661-662,共2页 Journal of Clinical Urology
关键词 血清 前列腺特异抗原 前列腺癌 病理分级 临床分期 预后 Prostate specific antigen Prostate carcinoma Pathology grade Clinic by stages
  • 相关文献

参考文献2

二级参考文献9

  • 1杨柳平,国外医学.泌尿系统分册,1998年,18卷,33页
  • 2杨苎,中华泌尿外科杂志,1996年,17卷,740页
  • 3侯建国,中华泌尿外科杂志,1995年,16卷,357页
  • 4夏同礼,中华泌尿外科杂志,1995年,16卷,345页
  • 5方祖军,中华泌尿外科杂志,1994年,15卷,364页
  • 6徐耀庭,中华泌尿外科杂志,1994年,15卷,192页
  • 7赵长林,中华泌尿外科杂志,1993年,14卷,120页
  • 8黄翼然,中华泌尿外科杂志,1992年,13卷,369页
  • 9徐卓群,中华泌尿外科杂志,1992年,13卷,372页

共引文献18

同被引文献27

  • 1华立新,吴宏飞,眭元庚,徐正铨,张炜,钱立新,居小兵,张杰秀.比卡鲁胺治疗激素抵抗性前列腺癌[J].中华泌尿外科杂志,2005,26(6):383-385. 被引量:9
  • 2马腾骧.现代泌尿外科学[M].天津科学技术出版社,2001.513-519.
  • 3Narayar P,Gajendran V,Taglor SP,et al.The role of transrectal ultrasound-guided biopsy-based staging,preoperative serum prostate-specific antigen,and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer[J].Urology,1995,46:205-212.
  • 4Catalone WJ,Smith DS,Ratliff TL.Prostate-specific antigen of detecting prostate cancer[J].N Eng J Med,1991,321:1156-1161.
  • 5Martinez JM,Garcia MF.Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer[J].Acras Urol Esp,2003,27(6):442-449.
  • 6Okegawa T,Noda H,Ohta M,et al.Use of various combinations of free,complexed and total prostate-specific antigen levels of the pathologic stage of prostate cancer[J].Int J Urol,2001,8(8):438-443.
  • 7Han M,Gann PH,Catalona WJ.Prostate-specific antigen and screening for prostate cancer.Med Clin North Am 2004;88(2):245-265
  • 8Lieberman R.Evidence-based medical perspectives:the evolving role of PSA for early detection,monitoring of treatment response,and as a surrogate end point of efficacy for interventiOns in men with different clinical risk states for the prevention and progression of prostate cancer.Am J Ther 2004;11(6):501-506
  • 9Punglia RS,D'Amico AV,Catalona WJ,et al.Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.N Engl J Med 2003;349(4):335-342
  • 10Morgan TO,Jacobsen SJ,McCarthy WF,et al.Age-specific reference ranges for prostate-specific antigen in black men.N Engl J Med 1996;335(5):304-310

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部